| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1089-3261(02)00019-3 |
| P8608 | Fatcat ID | release_wcpca3nqhnhvvelund66ffeuwu |
| P698 | PubMed publication ID | 12362570 |
| P2093 | author name string | Ian G McFarlane | |
| P2860 | cites work | Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis | Q24681787 |
| Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis | Q28115454 | ||
| Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis | Q28248157 | ||
| Management and outcome of pregnancy in autoimmune hepatitis | Q28345133 | ||
| Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. | Q30846833 | ||
| Type I autoimmune hepatitis is primarily a disease of later life | Q33500376 | ||
| International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Q33784003 | ||
| Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors | Q34094790 | ||
| LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase | Q34205552 | ||
| Early-onset autoimmune hepatitis is associated with a C4A gene deletion. | Q34364096 | ||
| Genetic predispositions for the immunological features of chronic active hepatitis | Q70496840 | ||
| Meeting report: International Autoimmune Hepatitis Group | Q70496892 | ||
| Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases | Q70588163 | ||
| Chronic active hepatitis in alcoholic patients | Q71110528 | ||
| Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis | Q71506734 | ||
| Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis | Q71748722 | ||
| Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis | Q72164385 | ||
| Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents | Q72333198 | ||
| How many types of autoimmune hepatitis are there? | Q72566326 | ||
| The nature and prognostic implications of autoimmune hepatitis with an acute presentation | Q72631955 | ||
| Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C-related chronic liver disease in Sweden. Swedish Internal Medicine Liver club | Q73113401 | ||
| Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system | Q73144379 | ||
| Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis | Q73156189 | ||
| Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis | Q73319909 | ||
| Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study | Q73568156 | ||
| Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis | Q73671708 | ||
| Duration of immunosuppressive therapy in autoimmune hepatitis | Q73700106 | ||
| Lessons about antibodies in autoimmune hepatitis | Q73761063 | ||
| A 12-year-old girl with antimitochondrial antibody-positive autoimmune hepatitis | Q73867052 | ||
| Autoimmune Hepatitis Overlapping With Primary Sclerosing Cholangitis in Five Cases | Q74642745 | ||
| Behavior and significance of autoantibodies in type 1 autoimmune hepatitis | Q77221650 | ||
| Chronic liver disease in young people. Clinical features and course in thirty-three patients | Q79108157 | ||
| Controlled trial of prednisone and azathioprine in active chronic hepatitis | Q93735616 | ||
| Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. | Q34396552 | ||
| Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection | Q34408327 | ||
| Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile | Q34439843 | ||
| Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis | Q34477251 | ||
| Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin | Q34598372 | ||
| The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis | Q35350742 | ||
| Hepatitis B virus DNA contains a glucocorticoid-responsive element | Q35594395 | ||
| Autoantibodies in alcoholic liver disease | Q37767452 | ||
| Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition | Q38318118 | ||
| Autoimmune hepatitis in older patients. | Q41702370 | ||
| Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis | Q42106972 | ||
| Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. | Q42978301 | ||
| Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity | Q42985404 | ||
| Virus-induced autoimmunity in hepatitis C virus infections: a rare event | Q43035417 | ||
| Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis | Q43036529 | ||
| Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis | Q43039107 | ||
| Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States | Q43048900 | ||
| Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis | Q43627009 | ||
| Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience | Q43645710 | ||
| Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis | Q44086661 | ||
| The course of infectious hepatitis with special reference to prognosis and the chronic stage | Q44890884 | ||
| Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa. | Q45768672 | ||
| Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. | Q45860667 | ||
| Liver/kidney microsome antibody type 1 and hepatitis C virus infection | Q45872748 | ||
| High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis | Q45998281 | ||
| LKM-positive autoimmune hepatitis in the western United States: a case series | Q46106618 | ||
| Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis | Q46796618 | ||
| Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis | Q50542465 | ||
| Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis? | Q50897195 | ||
| Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis | Q50948422 | ||
| Prognosis of histological cirrhosis in type 1 autoimmune hepatitis | Q51035941 | ||
| Autoimmune hepatitis in childhood: a 20-year experience | Q53361457 | ||
| Autoimmune hepatitis in the elderly | Q58131254 | ||
| Polymorphism in the Human Complement C4 Genes and Genetic Susceptibility to Autoimmune Hepatitis | Q58143700 | ||
| Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2 | Q58852141 | ||
| Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies | Q67260794 | ||
| Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis | Q67555835 | ||
| Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis | Q67705022 | ||
| Alpha-Interferon Treatment of Chronic Hepatitis C: Need for Accurate Diagnosis in Selecting Patients | Q67716326 | ||
| Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis | Q69544750 | ||
| Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders | Q69695373 | ||
| The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients | Q69735321 | ||
| Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis | Q69867245 | ||
| Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen | Q69893348 | ||
| P433 | issue | 3 | |
| P921 | main subject | autoimmune hepatitis | Q786844 |
| P304 | page(s) | 605-621 | |
| P577 | publication date | 2002-08-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Clinics in liver disease | Q26842322 |
| P1476 | title | Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features | |
| P478 | volume | 6 |
| Q86886381 | Autoimmune hepatitis |
| Q86954391 | Autoimmune hepatitis |
| Q38103631 | Autoimmune hepatitis in diverse ethnic populations and geographical regions |
| Q36574524 | Autoimmune hepatitis--approach to diagnosis. |
| Q46196074 | Autoimmune hepatitis: An evolving demography? |
| Q26766699 | Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liver |
| Q43860532 | Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study |
| Q82640069 | Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly |
| Q39436336 | Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis |
| Q42723758 | Optimizing management in autoimmune hepatitis with liver failure at initial presentation |
| Q51539848 | Population-based epidemiology study of autoimmune hepatitis: a disease of older women? |
| Q46330714 | Pregnancy outcome in women with autoimmune hepatitis |
| Q37099400 | Pregnancy with autoimmune hepatitis |
| Q37051229 | Serum autoantibodies: a road map for the clinical hepatologist |
| Q27477969 | Steatosis affects chronic hepatitis C progression in a genotype specific way |
| Q37289575 | Study of nonstandard auto-antibodies as prognostic markers in auto immune hepatitis in children |
| Q24801439 | The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C |
Search more.